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Abstract
One of the promising strategies for neural repair therapies is the transplantation of olfactory ensheathing cells (OECs) which
are the glial cells of the olfactory system. We evaluated the effects of curcumin on the behaviour of mouse OECs to
determine if it could be of use to further enhance the therapeutic potential of OECs. Curcumin, a natural polyphenol
compound found in the spice turmeric, is known for its anti-cancer properties at doses over 10 mM, and often at 50 mM, and
it exerts its effects on cancer cells in part by activation of MAP kinases. In contrast, we found that low-dose curcumin
(0.5 mM) applied to OECs strikingly modulated the dynamic morphology, increased the rate of migration by up to 4-fold,
and promoted significant proliferation of the OECs. Most dramatically, low-dose curcumin stimulated a 10-fold increase in
the phagocytic activity of OECs. All of these potently stimulated behavioural characteristics of OECs are favourable for neural
repair therapies. Importantly, low-dose curcumin gave a transient activation of p38 kinases, which is in contrast to the high
dose curcumin effects on cancer cells in which these MAP kinases tend to undergo prolonged activation. Low-dose
curcumin mediated effects on OECs demonstrate cell-type specific stimulation of p38 and ERK kinases. These results
constitute the first evidence that low-dose curcumin can modulate the behaviour of olfactory glia into a phenotype
potentially more favourable for neural repair and thereby improve the therapeutic use of OECs for neural repair therapies.
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Introduction
Transplantation of olfactory ensheathing cells (OECs) for neural
repair therapies has been the subject of markedly increasing
research over the last decade. The glial cells from the olfactory
system have a number of attributes that make them particularly
favorable and place them at the upper end of potentially useful
cells. OECs have been shown to reduce inflammation [1],
promote axon regeneration [2–5], phagocytose cellular debris
[6–8] and bacteria [9,10], as well as integrate with astrocytes to
potentially allow them to penetrate astrocytic glial scar tissue
[11,12]. When transplanted into the injured spinal cord in rodents
[13–17] and dogs [18], OECs have been shown to promote axonal
regeneration and improve functional restoration. It is known that
the beneficial effects of OEC transplantations are mediated by
different mechanisms, including the creation of a nerve-promoting
environment, the production of neurotrophic factors, reduction of
inhibitory factors and the remyelination of the damaged nerves
[19]. However, OEC transplant results can be variable with some
studies concluding that no significant differences in axon
regeneration or functional outcomes were achieved after OEC
transplantation [20–22]. The factors for these contradictory
outcomes are diverse, however OEC transplantation appears to
be safe and offers unique properties as a leading candidate in
transplantation therapies for nerve repair [23]. A deeper
understanding of the biology of OECs as well as the identification
of molecular factors that can further enhance OEC properties are
highly warranted to develop a better strategy in the use of OECS
in cellular therapies.
Curcumin, a natural polyphenol compound found in the spice
turmeric, is known for its anti-inflammatory and anti-cancer
properties and has been used in traditional Chinese and Indian
medicine for centuries [24]. High concentrations of curcumin (10–
50 mM) induced apoptosis and autophagy in different types of
cancer cells by activation of extracellular signal-related (ERK) and
p38 MAP kinases [25]. However, curcumin can exert a dual effect
in some cell types depending on the dosage [26]. In neural
progenitor cells, high doses of curcumin (20–50 mM) are cytotoxic
whereas low doses (0.1–0.5 mM) stimulate cell proliferation [27].
Therefore, curcumin at different doses can elicit different cell
responses while activating the same kinases pathways.
The effect of curcumin on glial cells has been examined on
Schwann cells and astrocytes. Curcumin (2–10 mM) promote
Schwann cell differentiation and improve neuropathy in model of
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early onset Charcot-Marie-Tooth disease [28]. Within the injured
spinal cord, curcumin has been reported to have anti-inflamma-
tory and anti-oxidative effects [29,30] at concentration of 40–
60 mg/kg and to be neuroprotective by reducing neuron loss and
minimizing activation of astrocytes (1 mM) [31]. To date, however,
the effect of curcumin on the behaviour of OECs has been not
determined.
In this study, we have examined the effect of curcumin on the
behaviour of mouse OECs using time-lapse microscopy. We found
that curcumin dramatically stimulated the dynamic activity of
OECs leading to a potent increase in the phagocytic activity as
well as increased migration and proliferation. These results
provide further insight into the cellular mechanisms that regulate
phagocytic activity of OECs. In addition, as neuronal growth is
dependent on the growth and behaviour of glia, these results
indicate that curcumin could be used to enhance the activity of
OECs and subsequently improve neural regeneration in cell
transplant therapies.
Materials and Methods
Animals
Two different transgenic reporter mouse lines were used: (1)
OMP-ZsGreen mice, in which the olfactory marker protein
promoter drives expression of ZsGreen fluorescent protein in
primary olfactory sensory neurons [32]; (2) S100ß-DsRed mice in
which the human S100ß promoter drives expression of DsRed
fluorescent protein in cells that express S100ß including OECs
[33]. S100ß-DsRed transgenic mice were used for obtaining
cultures of DsRed-OECs; OMP-ZsGreen transgenic mice were
used for explant cultures of olfactory mucosa and for generating
fluorescently labelled cellular debris from olfactory axons.
Breeding pairs of mice were housed in micro-isolation cages and
postnatal day 7 (P7) offspring (n = 3–6 male/female pups per assay)
were sacrificed by decapitation.
Ethics Statement
Animals were used with approval of the animal ethics
committee of Griffith University (permit number: ESK/05/12/
AEC). All experiments were implemented according to the
guidelines established by National Health and Medical Research
Council of Australia (NHMRC).
OEC cultures
OECs were purified from the lamina propria of S100b-DsRed
transgenic mice using our previously published techniques [33]; in
these mice OECs express the bright fluorescent red protein
DsRed. Cells were maintained in Dulbecco’s Modified Eagle
Medium (DMEM) with 10% fetal bovine serum, G5 supplement
(Invitrogen), gentamicin, L-glutamine and 5% CO2 for one week
and then replated for analyses.
Verification of OEC identity
Immunochemistry was used to verify the identity of the DsRed-
positive OECs. For in vivo verification, heads from postnatal day 7
S100ß-DsRed mice were fixed in 4% paraformaldehyde (PFA) at
4uC for 24 h, cryoprotected in 30% sucrose, frozen and sectioned
on a cryostat microtome in 30 mm thick sections. For in vitro
immunocytochemistry, OECs were fixed in 4% PFA for 10 min.
Cryostat sections or cultured OECs were incubated for 30 min at
room temp in 0.1 M phosphate buffered saline (PBS) with 2%
bovine serum albumin (BSA) and 0.3% Triton X-100 (TX).
Rabbit polyclonal anti-p75 ntr (1:500, Promega, G3231, raised
against the cytoplasmic domain of recombinant human p75,
AB_430853 [34]) or rabbit polyclonal anti-S100ß (1:500, Dako,
Z031129-2, raised against full length S100 isolated from cow
brain, AB_2315306 [35]) antibodies (Table S1) were diluted in 0.1
M PBS/2% BSA/0.3% TX. Cells and tissue sections were
incubated with the antibodies overnight at 4uC, washed and
incubated with goat anti-rabbit secondary antibodies conjugated
to Alexafluor 488 (1 mg/mL, Invitrogen, AB_10049650) or
Alexafluor 594 (1:200, Invitrogen, AB_10049744) in PBS/BSA/
TX at room temp for 1 h and then stained with DAPI to visualise
nuclei.
Generation of immortalized mOEC-GFP cells
Primary cultures of olfactory bulb ensheathing glia were
prepared from GFP-expressing mice (C57BL/6-Tg(ACTB-EGF-
P)1Osb/J, Jackson Laboratory, Bar Harbor, USA) by a previously
described method [36,37] with modifications. Briefly, superficial
layers of olfactory bulbs from postnatal day 11 (P11) mice were
dissected out and the tissue dissociated. After incubation of 15 min
with 0.1% trypsin in Hank’s buffered salt solution (HBSS),
digestion was stopped with 20% fetal calf serum (FCS) in HBSS,
and the cells centrifuged and dissociated by several passes through
Pasteur pipettes. The OECs seeded in 6 cm tissue culture plates
were pretreated with poly-L-lysine and were maintained in
DMEM-F12 supplemented with 10% FCS, 20 mg/ml pituitary
extract and 2 mM forskolin (ME) until confluence was reached.
Immortalized clonal lines were established by transfection of the
primary cultures with the plasmid pEF321-T, which expresses the
viral oncogene SV40 large T antigen under the control of the EF1
promoter [38] using Lipofectamine (Gibco-BRL Life Tech.) as
indicated by the manufacturer’s instructions. Three clones (1, 2
and 3) with rapid growth in DMEM supplemented with 10% fetal
calf serum (FCS) were selected by limited dilution and re-cloned
twice. After their initial selection, the clonal lines were maintained
in ME. All three clones were also confirmed as positive for axonal
regenerative activity using a rat retinal ganglion neuron co-culture
assay [39].
For immunocytochemical characterisation, cells were seeded on
coverslips (36103 per coverslip) and after 2 days of culture, fixed
with 4% paraformaldehyde in phosphate-buffered saline (PBS)
followed by incubation with anti-p75ntr and anti-S100ß antibodies
(Table S1) as described above for verification of the identity of the
DsRed mouse OECs.
Curcumin
Curcumin (purity.80%) was obtained from Sigma (catalogue
number C7727) and a stock solution (30 mM) was prepared in
DMSO. For cell treatments, stock solution of curcumin was
diluted in culture medium to the concentration of 0.1, 0.5, 1, 10
and 20 mM. Treatments were always added 24 h post-seeding.
Ontology map
The network map was generated using Ingenuity Pathway
Analysis (IPA) (http://www.ingenuity.com). IPA is built upon a
knowledge base comprised of extensive peer-reviewed literature.
The significance value (p,0.01) for network over-representation
was calculated using a right-tailed Fisher’s exact test.
Proliferation assay
To examine the effect of curcumin on the proliferation of
primary cultures of OECs, cells were plated into 96 well plates at a
density of 3000 cells per well in total media for 24 h and then
exposed to different treatments (1) control medium (DMEM, 10%
FBS, gentamicin, L-glutamine), or media containing (2) increasing
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Figure 1. Immunofluorescence of OECs in vivo and in vitro. (A–A99) A cross section through olfactory nerve bundles within the lamina propria
of a postnatal day 7 mouse pup; OECs that surrounded and formed the nerve bundles expressed S100b-DsRed (A) and p75ntr (A9); the merged image
together with nuclei stained with DAPI is shown in A99. (B–B99) In cultures of purified OECs, the OECs continued to express DsRed (B); 95% of DsRed
OECs were positive for anti-p75ntr immunostaining (B9); the merged image is shown in B99 together with nuclei which are stained with DAPI. Arrow in
B99 points to a cell that did not express DsRed or p75ntr. (C–D) Characterization of clonal cell line of mouse OECs expressing GFP. OECs were positive
for anti-s100b (C) and anti-p75ntr (D). Scale bar = 50 mm in A–A99, C–D; 100 mm in B–B99.
doi:10.1371/journal.pone.0111787.g001
Figure 2. Low-dose curcumin treatment increases OEC proliferation. (A–D). Increased proliferation of OECs was observed after treatment
with 0.5 mM curcumin (B) or 0.5 mM curcumin combined with G5 supplement (D); cells appeared to have longer processes and formed a net-like
structure. Cells treated with higher concentrations of curcumin (C) displayed a more flattened morphology (arrows) and the number of cells was
lower compared to the control (A). Scale bar = 100 mm in A–D. (E–F) Quantification of the proliferation rate in MTS assays. (E) After two days in culture
0.5 mM curcumin with or without G5, and G5 supplement alone had significantly higher proliferation compared to control treatment. Higher doses of
curcumin (10, 20 mM) showed a significant decrease in OEC proliferation compared to control treatment p,0.05 (*), p,0.001 (**). After four days in
culture, 1 mM curcumin, 0.5 mM curcumin with G5, and G5 supplement alone significantly increased OEC proliferation; whereas 10 mM and 20 mM
curcumin decreased proliferation compared to control treatment (F). p,0.05(*), p,0.001(**), one way ANOVA post-hoc Tukey test. (G) ERK (PD98059)
and p38 kinase (SB203580) inhibitors blocked curcumin-induced proliferation of OECs p,0.05 (*); p,0.01 (**) compared with control; p,0.01 (##)
compared with cultures treated with curcumin alone; (n = 30–36 cells per treatment). Values are expressed as mean 6 s.e. of triplicates. Low-dose
curcumin induced transient-activation of ERK and p38 MAP kinases in OEC cells (H). Whole cell extracts (40 mg for p–p38 and 20 mg for p-ERKs) from
OECs treated with and without curcumin (0.5 mM) for the indicated time periods were subjected to western blot analysis using antibodies against
phospo-ERK1/2 and phospo-p38. Data represent the mean of three independent experiments 6 s.e. Statistical significance was determined by
Student’s t-test p,0.05 (*). Levels of b-tubulin were used as loading control.
doi:10.1371/journal.pone.0111787.g002
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concentrations of curcumin (0.1, 0.5, 1, 10, 20 mM (3) G5
supplement (Invitrogen), or (4) a combination of G5 and 0.5 mM
curcumin. G5 supplement was used as a positive control since G5
is known to stimulate proliferation of OECs [40]. For these assays
we used primary cultures of OECs dissected from transgenic
reporter mice as we have previously characterised these cells
[33,40,41].
After two or four days of treatment, proliferation of OECs was
determined by colorimetric assay using MTS assay CellTiter96
Aqueous One Solution reagent (Promega, Madison, WI) for 1 h
with absorbance at 490 nm measured in a plate reader. Images of
all wells were also taken before and after the set time period to
verify proliferation assay results. Inhibition of proliferation was
assayed using ERK (Extracellular signal-regulated kinases) and
p38 MAP (mitogen-activated protein) kinase inhibitors to block
curcumin-induced proliferation of OECs. Cultures of purified
S100b-DsRed OECs were plated in 96 well plates. After 24 h cells
were incubated with the inhibitors SB203580 (p38 MAP kinase
inhibitor, Sigma-Aldrich) and PD98059 (MEK/ERK inhibitor,
Sigma-Aldrich) at 100 mM for 24 h and then treated with 0.5 mM
curcumin for 48 h, followed by MTS assays and morphological
assays as describe above to determine the effects of p38 and ERK
kinases inhibitors in OEC lamellipodia.
Western blotting
Cell line OECs were cultured on six wells plates. After the cells
reached 70% confluence, curcumin (0.5 mM) treatment was
applied by direct dilution into the culture medium and samples
Figure 3. Ontology map of molecular and pathway interactions with curcumin. The ontology map was generated by IPA and identified
numerous molecules that interacted with curcumin. The five biological processes listed on the right that operated through the associated molecules
were all significantly over-represented (p,0.05).
doi:10.1371/journal.pone.0111787.g003
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collected at different time points (0.5, 1, 2, 4, 6 and 12 h). Cell
pellets obtained from each time point were washed with HBSS
and RIPA lysis buffer (150 mM NaCl, 1.0% Triton X-100, 0.5%
sodium deoxycholate, 0.1% sodium dodecyl sulphate, 50 mM
Tris, pH 8.0). Homogenized and lysed samples were boiled for
5 min in a gel-loading buffer at a sample/buffer ratio 1:2. Equal
amounts of protein (40 mg for p–p38 and 20 mg for p-ERKs) were
separated by SDS-PAGE using 10% gels. Proteins were
transferred from the gel onto a PVDF transfer membrane
(Thermo Fisher Scientific). Membrane was placed in blocking
solution (5% skim dry milk in TBS-Tween (TBS-T) buffer) for
30 min at room temp. Primary antibodies (Table S1): mouse
monoclonal antibodies against phospo-ERK (1:1000, Cell signal-
ling, 9101) [42] and phospo-p38 (1:500, Cell Signaling Technol-
ogy, 9211) [43] were incubated overnight at 4uC followed by
horseradish peroxidase (HRP) (1:5000 Life Technologies, 65–
6120) for 3 h at room temp. Bands were visualized using a
chemiluminescence kit (Millipore). Levels of phospo-p38 and
phospo-ERKS relative to b-tubulin (1:2000, Cell Signaling, 2128S)
were quantified by densitometric analysis and expressed in
arbitrary units.
Phagocytosis assays
To determine how curcumin affected the degree of OEC-
mediated phagocytosis, whole explants of olfactory mucosa tissue
were cultured in the absence and presence of 0.5 mM curcumin.
Explants were established from crosses of OMP-ZsGreen and
S100ß-DsRed transgenic mice as described previously [32,33].
The cultures were imaged after four days in culture to visualise the
green fluorescent axonal debris within OECs.
To verify that OECs phagocytosed fragments from olfactory
neurons, we generated green fluorescent axonal debris from
OMP-ZsGreen mice by dissecting out the nerve fibre layer and
briefly digesting the axons with a lysis buffer (TrypLE Express (Life
Technologies) and collagenase (0.1 mg/mL, Life Technologies))
followed by trituration. We used OECs from S100b-DsRed
transgenic mice so that they did not contain any ZsGreen axonal
debris prior to the assay. OECs were plated at the same density
(66103 cells/chamber in 8-well glass chamber slides) and the same
amount of axonal debris was added to the medium (50 ml) and
imaged over time. The axonal debris (identifiable by expression of
ZsGreen protein) was added to dissociated cultures of DsRed
OECs. Cells were studied using time-lapse imaging. LysoTracker
Red DN-99 (Molecular Probes, 1 mM) staining was carried to
determine co-localization of the cellular debris with lysosome by
confocal microscope. Phagocytosis of bacteria was conducted
using heat-killed FITC labelled E. coli.
For quantification of phagocytosis of axonal debris, after 12 and
24 h the dissociated OEC cultures were washed to remove
external axonal debris, fixed in 4% PFA and imaged using
confocal microscopy. Confocal microscope images were taken of
the dissociated cells (seeding density: 66103 cells/chamber in 8-
well glass chamber slides)with the laser and imaging parameters
Figure 4. Curcumin increases the phagocytic activity of OECs in explant cultures. (A) In explants in control medium some OECs
(arrowheads) migrated out from explants (large solid mass) and axonal debris (numerous small dots, arrows) was present in the medium. (B) Higher
magnification view of OECs migrating out of an explant together with green axon debris in control medium. Axonal debris was present in the
medium (arrows) as well as within the OECs (arrow with tail); a migrating neuron is indicated (arrowhead); B9 ZsGreen debris was present in the
medium (arrows); B99 red fluorescence of OECs. (C) When grown in medium containing 0.5 mM curcumin, numerous OECs had migrated out of the
explant and contained high levels of green axon debris (arrows), and there was little axon debris in the medium. (D) Higher magnification view shows
accumulation of ZsGreen within OECs (arrows); D9 ZsGreen debris was not detected in the medium (arrows with tail); D99 red fluorescence of OECs.
Scale bar = 100 mm in A, C; 45 mm in B, D.
doi:10.1371/journal.pone.0111787.g004
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held constant (473 laser at 6.0% power and PMT voltage of 607)
and with the levels set so that saturation of the green fluorescent
channel (to visualise axon debris) did not occur. Quantification of
the amount of internalised axonal debris was performed using
ImageJ software to measure the mean intensity of green
fluorescence (8 bit images were used giving a range of 0–255)
within the entire cell boundaries as defined by the DsRed
fluorescence of the cells.
Live Cell Imaging
For all experiments where live cell imaging was used, OECs
were plated onto glass culture plates (66103 cells/chamber in 8-
well glass chamber slides) and imaged in CO2 independent
medium (Invitrogen) in a chamber maintaining cells at 37uC.
Epifluorescent live cell imaging was carried out using a
Hamamatsu digital camera on an Olympus IX81 CellR micro-
scope fitted with epifluorescence and differential contrast optics
with time-lapse images taken every 10 min for up to 24 h. For
Figure 5. Curcumin increases the phagocytic activity of OECs in vitro. (A–A9) After 24 h OECs in control medium accumulated a small
amount of axonal debris (arrows) whereas (B–B9) OECs treated with curcumin showed high accumulation of axonal debris localized inside the cell
body. (C–C9) Co-localization of cellular debris (green) with lysosomes (red) indicating internalization of the debris. (D) Densitometric quantification of
the amount of axonal debris within OECs after 12 and 24 h incubation; graph shows a box and whisker plot, **p,0.001 for Mann-Whitney U test for
independent samples, n = 20. (E–F) OECs treated with curcumin show higher phagocytosis of FITC-labelled E. coli. (G–H) Live cell imaging of OECs in
control medium (G) and with curcumin (H); time is in h:min. (G) In control medium, lamellipodia were present (arrow with tail) and axon debris
external to the OEC (arrow) was internalised by the OEC over time. (H) When incubated with curcumin, large motile lamellipodia were present (arrow
with tail) and axon debris was rapidly internalised (arrowhead). Entire sequences are shown in Movie S1 and Movie S2. Scale bar = 25 mm in E–F
10 mm in C; 25 mm in E–F; 35 mm in G–H.
doi:10.1371/journal.pone.0111787.g005
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Figure 6. Curcumin increases OECs migration rate. (A) An example of live cell OEC migration in dissociated cultures with the track of migration
visualised using AxioVision software from the first (arrowhead) to last (arrow) frame. (B) Average migration rate from three different time-lapse videos
for each treatment, with n= 10 cells in each treatment. OECs treated with 0.5 mM curcumin and/or G5 migrated significantly faster than control; cells
exposed to combined 0.5 mM curcumin/G5 were significantly faster than all other treatments. (C–E) Migration of individual OECs in a scratch assay: (C)
the displacement of OECs that entered the scratch; (D) the mean velocity as measured along the tortuous path of migration; (E) the number of cells
that had migrated into the scratch region. Values are the mean and s.e. (n = 3 cultures) *p,0.05 and **p,0.01 Friedman non parametric test.
doi:10.1371/journal.pone.0111787.g006
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Figure 7. Curcumin increases morphology dynamics of OECs. (A–B) Schematic representation of the dynamic activity of OECs in vitro during
2 h of time-lapse imaging. (A) In control medium the morphology of cells underwent little change, (B) when incubated with 0.5 mM curcumin the
cells underwent rapid changes in morphology with increased size of lamellipodia and formation of branches. (C) OECs in control media showed
typical bipolar morphology with a long process (arrow) and lamellipodia (*). (D) OECs treated with curcumin displayed dynamic morphology with
rapid retraction and extension of branches (arrow) and numerous and larger lamellipodia (*). Scale bar = 60 mm. (E–H) OECs treated with curcumin
Curcumin Stimulates Activity of Olfactory Glia
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some assays, confocal live cell imaging was carried out on an
Olympus CV1000 confocal microscope with images taken every
3 min.
Morphology assay
Time-lapse image sequences were analysed using AxioVision
(Zeiss, Germany) software to track the migration of cells. Image J
software (freehand/segmented line tools) was used to measure the
area of lamellipodia and length of branches. Counts of the number
of branches and lamellipodia were also performed. To evaluate the
changes in OEC lamellipodia after addition of ERK (Extracellular
signal-regulated kinases) and p38 MAP (mitogen-activated protein)
kinase inhibitors, cultures of purified S100b-DsRed OECs were
plated in 96 well plates. After 24 h cells were incubated with the
inhibitors SB203580 (p38 MAP kinase inhibitor, Sigma-Aldrich)
and PD98059 (MEK/ERK inhibitor, Sigma-Aldrich) at 100 mM
for 24 h and then treated with 0.5 mM curcumin for 48 h,
followed by morphological assays as described above.
Migration assays
To investigate how curcumin affected migration of OECs, cells
were tracked over 24 h in the absence and presence of curcumin
(0.5 mM). To study multidirectional migration within dissociated
cell cultures, cells were cultured to 50% confluency and then
imaged every 10 min for 24 h using time-lapse live cell imaging.
Quantification of the migrated distance for individual cells was
performed on every second frame and the average migration rate
over entire period was calculated using Axiovision software. For
scratch assays, OECs were cultured to 70% confluency followed
by serum starvation for 24 h. After that, a wide scratch (,700 mm)
was made using a pipette tip. Cells were left to migrate for 24 h
during which individual cell migration was tracked using live-cell
time-lapse microscopy with images taken every 10 min. The
number of cells that had entered the scratched region was counted
and Image J software was used to measure (1) the mean migration
velocity over the entire path of movement and (2) the final
displacement (s) of the cells from their initial position. Cell
migration analyses were performed by tracking individual cells
over the course of the live-cell imaging period both in the
dispersed cultures and in scratch assays.
Statistical analyses
To determine whether the data was normally distributed,
normality tests (skewness and excess kurtosis coefficients) were
used. Measurements of proliferation and morphological parame-
ters (lamellipodia and branches) were tested for statistical
significance using ANOVA one-way Tukey and LSD post-hoc
analyses. Statistical significance of cell migration data collected
from tracking cells in AxioVision was tested using Friedman non-
parametric test. Phagocytosis data statistical significance was tested
using Mann-Whitney U test.
Results and Discussion
Purification of OEC cultures
To easily visualise and identify OECs in vivo and in vitro, we
used the previously generated S100ß-DsRed mice in which the
human S100ß promoter drives expression of DsRed in OECs [33].
We first verified the expression of DsRed by OECs in vivo in
healthy postnatal pups (n = 3) using tissue sections through the
olfactory nerve bundles within the lamina propria lining the nasal
septum. Immunostaining using antibodies against the p75
neurotrophin receptor, which is a standard marker of OECs,
showed that all OECs expressed both DsRed fluorescent protein
and p75 neurotrophin receptor (Fig. 1A–A0). After purification,
in vitro cultures of OECs showed that 95% of cells expressed
DsRed fluorescent protein (Fig. 1B) and 95% of the DsRed cells
also expressed the p75 neurotrophin receptor (Fig. 1 B9–B0) and
thus these OEC cultures had a purity of at least 90%. The
had significantly higher (E) number of branches, (F) length of branches, (G) number of lamellipodia, (H) area of lamellipodia. (I) OECs treated with
SB203580 and PD98059 inhibitors had significantly fewer (*p,0.05) lamellipodia compared to control cells (n = 30–36 cells per treatment). Values are
expressed as mean 6 s.e. of triplicates. *p,0.05, **p,0.01, one-way ANOVA (Tukey Post-hoc analysis).
doi:10.1371/journal.pone.0111787.g007
Figure 8. Curcumin can be of potential use for transplant
therapies. (A) Typically OECs transplanted into the injured spinal cord
have limited migration and integration. (B) Structure of curcumin. (C)
Curcumin stimulates proliferation and migration of OECs and strongly
promotes phagocytosis of cellular debris. (D) The potential resultant
effect is to improve the integration of OECs within the injury site and
promote axon growth.
doi:10.1371/journal.pone.0111787.g008
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morphology of the cells in these primary cultures was predomi-
nantly bipolar.
Curcumin increases proliferation of OECs
As curcumin has been shown to regulate the proliferation of
neural progenitors [27] we determined whether curcumin
regulates the proliferation of OECs. We assayed curcumin at the
concentrations of 0.1, 0.5, 1, 10, 20 mM and found that curcumin
at low dose (0.5 mM) promoted proliferation of OECs, whereas at
higher concentrations ($10 mM), proliferation was instead re-
duced (Fig. 2A–C). In the curcumin treated wells, proliferation
was not uniform across the wells with localised regions showing
considerably higher concentrations of cells, particularly those that
had close cell-cell contact (Fig. 2B). Interestingly, cells treated with
the combination of curcumin and G5 showed the highest
proliferation (Fig. 2D). Proliferation rates were calculated to
confirm the results. After two days of incubation, there was a
significant increase of OEC proliferation in cultures treated with
0.5 mM curcumin (p,0.05), G5+0.5 mM curcumin (p,0.01) and
G5 alone (p,0.05) (Fig. 2E). Curcumin at concentrations of 10
and 20 mM curcumin had significantly lower rates of proliferation
compared to cells grown in control media (p,0.05; Fig. 2E). At
concentrations of 0.5–1.0 mM, the OECs had a largely bipolar
morphology and underwent increased proliferation in comparison
to controls (Fig. 2A, B). At concentrations above 1 mM, many of
the OECs adopted a flattened morphology, consistent with lower
dynamic activity (Fig. 2C) [33]. After four days of incubation,
1 mM curcumin, 0.5 mM curcumin with G5, and G5 alone
significantly increased proliferation compared to control media
(p,0.05; Fig. 2F). Concentrations of curcumin of $10 mM
significantly decreased proliferation compared to control media
(p,0.05; Fig. 2F).
Among the concentrations of curcumin tested, 0.5 mM was the
most effective in stimulating OEC proliferation, and this
concentration was used for all following assays. Curcumin has
been shown to regulate proliferation of other cell types in a similar
concentration-dependent manner. At low concentrations (0.1–
0.5 mM) curcumin stimulated cell proliferation of cultured multi-
potent neural progenitors cells [27], whereas high concentrations
of curcumin (.12.5 mM) are often cytotoxic to various cancer cell
lines [27,44].
To assess the role of the ERK and p38 kinase pathways in
curcumin-mediated cell proliferation, OECs were incubated with
PD98059 (ERK inhibitor) and SB203580 (p38 MAP kinase
inhibitor), which have been shown to block growth factor-induced
mitogen activation on OECs [45]. Both the ERK and p38 MAP
kinase inhibitors significantly reduced proliferation of OECs
grown without curcumin (Fig. 2G), suggesting that both pathways
play important roles in the basal proliferation of OECs. Incubation
with both inhibitors blocked the proliferative effect of curcumin
(Fig. 2G) indicating that MEK/ERK and p38 MAP kinase are
involved in the curcumin-mediated effect on proliferation of
OECs. Although, these results suggest that ERK and p38 kinase
pathways are involved in the proliferation of OECs as the
inhibitors significantly suppress the effect of curcumin, it is unclear
if the phosphorylation levels of these kinases in OECs change after
administration of curcumin.
Protein kinases regulate proliferation, survival, migration and
other cellular events. Activation of p38 MAP kinases by curcumin
has been reported in ovarian cancer cell lines, where curcumin was
able to induce cell apoptosis [46]. The effect of curcumin is
dependent on the cell types as curcumin differentially affects
proliferation of neural stem cells and non-neural cancer cells even
if the same MAP kinases pathways are activated [47].
Curcumin has been shown to selectively regulate the activation
of the ERK and p38 MAPK pathways in different cells types.
Curcumin (10–50 mM) induce cell apoptosis and autophagy
[46,48] in different cancer cells [25], whilst in neural progenitors,
curcumin (0.5 mM) was able to increase proliferation [27]. These
results suggest that the effect of curcumin is dependent on the cell
types and dosage, as curcumin differentially affects proliferation of
neural stem cells and non-neural cancer cells even if the same
MAP kinases pathways are activated [27]. As glial cells are of a
neural lineage, we therefore performed western blot analysis using
low-dose curcumin (0.5 mM) to determine if these kinases are
activated by curcumin treatment (Fig. 2H). We used the clonal cell
line of mouse OECs as these cells would provide a uniform
response to curcumin. The cell line OECs were confirmed positive
for expression of S100b and p75 neurotrophin receptor (Fig. 1 C–
D). Stimulation by curcumin (0.5 mM) transiently increased the
activation of p38 pathway at 6 h returning to basal levels within
12 h. A delayed activation of p38 in control cells was observed at
12 h. Levels of phosphorylated ERK-1 on curcumin cells treated
were reduced at 2 h with later peaks at 6 h and 12 h.
Phosphorylated ERK-2 showed activation at 6 h and 12 h. These
results suggest that low-dose curcumin stimulates the activity of
these MAP kinases in OECs. Previous studies have shown that
MAP signalling pathways are involved in multiple functions such
as proliferation, phagocytosis and generation of cytokine expres-
sion. Curcumin is known to regulate these pathways in a
differential manner according to the cell type [49].
Curcumin interacts with molecules and pathways
involved in different glial biology features
In order to identify other biological pathways associated with
curcumin that may be relevant to glia biology, we applied a
network knowledge database to highlight curcumin key functions
and interactions according to published literature. Ingenuity
Pathway Analysis (IPA) provides a bioinformatic method to build
first order molecular interactions and subsequently generate
pathways of highest significance from genome-wide expression
data [50]. Network nodes shown in Fig. 3 were all significantly
(p,0.01) over-represented in the first order curcumin network,
compiled from data validated in multiple model organisms. The
ontology map of molecular interactions of curcumin showed that it
has been implicated in pathways regulating phagocytosis of
microglia, activation of glia, differentiation of phagocytosis,
recruitment of phagocytes [51,52] and proliferation of immune
cells [53]. Curcumin has been reported to interact with numerous
molecular targets, including growth factors, inflammatory cyto-
kines, transmembrane receptors, transcription factors, protein
kinases and regulatory enzymes [54]. As the ontology analysis
indicated that curcumin may affect phagocytosis, migration and
morphology we therefore examined these behaviours in detail.
Curcumin modulates the behaviour of OECs in explants
of olfactory mucosa
The effect of curcumin on OEC behaviour was further
examined in cultured explants of olfactory mucosa. To easily
visualise olfactory sensory neurons, we used the previously
generated OMP-ZsGreen transgenic mice in which ZsGreen is
strongly expressed by the olfactory neurons and their axons [32].
The OMP-ZsGreen mice were crossed with the S100b-DsRed
transgenic mice so that explants of olfactory mucosa from the
offspring contained olfactory neurons that expressed ZsGreen
fluorescent protein, and OECs that expressed DsRed fluorescent
protein. After four days incubation in control medium (DMEM/
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10% FBS), OECs had started to migrate out of the explants
(Fig. 4A, B), however, extension of olfactory axons require
external growth factors to be present in the culture [40], and
thus no axons were seen in these cultures. A considerable amount
of axon-derived debris was present in the culture medium
immediately surrounding the explants (arrows, Fig. 4B). The
majority of OECs contained green fluorescent debris in the
cytoplasm, suggesting that the cells had phagocytosed the axonal
debris (arrow with tail, Fig. 4B).
In the presence of curcumin (0.5 mM), the number of OECs that
had migrated out of the explants, as well as the distance migrated,
was markedly increased (Fig. 4C vs 4A). At higher magnification it
appeared that the OECs contained considerably more green
fluorescent axonal debris than the cells in control medium (arrows,
Fig. 4D). Further, axonal debris could not be detected in the
medium surrounding the explant (arrows with tail, Fig. 4D9), in
stark contrast to the large amounts of debris observed under
control conditions (Fig. 4B9).
Since it was observed that curcumin appeared to induce
changes in phagocytic activity and migration on OECs, these
effects were further investigated.
Phagocytosis of axonal debris by OECs is potently
stimulated by curcumin
We examined the degree of phagocytosis of axonal debris in
dissociated cultures of OECs. After 24 h, OECs in control
medium had taken up small amounts of green fluorescent axonal
debris (Fig. 5A). The phagocytosis of axonal debris varied amongst
the OECs, with some OECs having taken up large amounts of
debris, while other OECs did not contain any debris at all
(Fig. 5A–A9). When OECs were incubated in medium containing
curcumin (0.5 mM) there was a dramatic difference in the
phagocytosis of axonal debris and all OECs in the culture
contained large amounts of axonal debris (Fig. 5B–B9). The OECs
in the curcumin cultures also exhibited numerous large lamelli-
podia emanating from the shafts of the cell processes and cell
bodies (arrows with tails, Fig. 5B) which were not detected on
OECs in control medium (Fig. 5A). We confirmed that the cell
debris was localized within lysosomes by using Lysotracker
(Fig. 5C–C9) and confocal imaging. We then quantified the
phagocytosis of the green fluorescent axonal debris by densito-
metric measurement of the fluorescent intensity contained within
the cells. The phagocytosis of axonal debris by OECs treated with
curcumin was significantly increased by over ten-fold after 12 h
incubation and over 5-fold after 24 h incubation compared to
controls (Fig. 5D). In addition to axonal debris, the phagocytosis
assay was also conducted using heat-killed FITC labelled E. coli.
OECs in curcumin media showed a dramatically higher amount of
bacteria inside the bodies when compared with OECs in control
media (Fig. 5E–F) suggesting that the increase in the phagocytic
activity is not limited to axonal debris.
Live cell imaging showed that OECs in control medium
displayed dynamic motility and morphology changes (Fig. 5G);
typically they had a long process emanating from the cell body that
extended and retracted over time as well as small motile
lamellipodia that moved along the process (arrow with tail,
Fig. 5G; Movie S1). In contrast, curcumin-treated OECs had large
lamellipodia that rapidly changed shape, and the cells moved
considerably faster and changed direction much more frequently
than OECs in control medium (Fig. 5H). OECs treated with
curcumin actively searched and rapidly internalized axonal debris
that came into contact with them (Movie S2). Interestingly,
activation of p38 kinases has been reported to be involved in the
engulfment of debris and to be required for the process of
phagocytosis of neuronal debris by OECs [55]. Therefore,
curcumin regulation of p38 and other MAP described previously
[27,56] may provide a new insight in the use of this natural
product for stimulation of OEC phagocytic activity.
The potent stimulation of phagocytosis by curcumin is of
particular interest for neural repair therapies. After spinal cord
injury, phagocytosis of dead nerve cells is crucial for creating a
favourable environment for nerve regeneration and restoration of
nerve connections [57]. In normal conditions, phagocytic microg-
lia travel to the site of the injury, engulf debris from dead and
damaged cells and secrete pro-inflammatory factors to promote
more cells to proliferate and do the same [58,59]. However, the
resultant inflammatory cascade can be harmful to cells because of
the release of oxygen free radicals and neurotoxic enzymes [60]. A
recent study showed that OECs in an in vitro model of spinal
injury phagocytosed degenerated neuronal debris which enhanced
not just neuron survival but neurite outgrowth [55]. Therefore
stimulation of phagocytosis by curcumin could promote a more
rapid and efficient clearing of the toxic debris by OECs,
diminishing down-stream posterior pro-inflammatory responses
given its known anti-inflammatory properties [29,30], facilitating
neuronal survival and axonal growth and therefore enhancing the
overall therapeutic effect of OEC in spinal cord injury repair cell
therapies.
Curcumin increases OEC migration
In our initial explant experiment (Fig. 4A), we observed that
OECs appeared to have migrated further in the presence than in
the absence of curcumin. Consequently we examined the effect of
curcumin on OEC migration using time-lapse microscopy. We
first examined the migration rate of individual OECs in dispersed
cultures by tracking the movement of the cell body during a 24 h
period after curcumin treatment (Fig. 6A). We included both
curcumin and G5 supplement in this series of experiments, and
thus the different conditions were as follows: (1) control medium,
(2) 0.5 mM curcumin, (3) G5 supplement, or (4) a combination of
0.5 mM curcumin and G5 supplement. Curcumin and G5
supplement, as well as the G5+curcumin, significantly increased
the migration rates of OECs in comparison to controls (p,0.05,
p,0.05 and p,0.01, respectively; Fig. 6B).
After careful assessment of the time-lapse imaging sequences, it
was apparent that the cell movements were strongly influenced by
the presence of neighbouring cells. Therefore, we examined
migration of individual OECs using a scratch assay which allowed
the cells to migrate into the cell-free scratch which may better
reflect conditions as were seen in the explant assays (Fig. 4A–D).
The cells did not migrate into the scratch in a straight line, but
instead followed a tortuous route. We performed two measure-
ments: (1) the displacement (s) of individual cells from their initial
starting point to the end of the imaging period and (2) the velocity
of individual cells taking into account the entire route. Both G5
and curcumin, alone or in combination significantly increased the
distance migrated into the scratch. However, incubation with
curcumin alone resulted in the most dramatic response (Fig. 6C).
Similarly, curcumin and G5 also increased the mean velocity of
migration when the entire route for each cell was taken into
account, and again, curcumin alone resulted in the largest
response, increasing the mean migration velocity almost three-
fold in comparison to control (Fig. 6D; p-values shown in figure
legend). Curcumin also significantly increased the number of cells
present in the scratch by over three-fold in comparison to control
(Fig. 6E), further corroborating our finding that curcumin
promotes migration of OECs.
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Curcumin modulates the morphology of OECs
Changes in the local environment may induce changes in the
morphology of OECs which affect their behavior [61–63] and
morphology plasticity strongly impacts the rate of migration of
OECs [64]. The changes in cell morphology observed in response
to the addition of curcumin in the proliferation and phagocytosis
assays were further explored using live cell imaging; the
morphology changes that occurred over time were determined
and quantified. Cultured OECs were incubated in (1) control
medium, (2) 0.5 mM curcumin, and (3) G5 supplement, imaged
every 10 min, and the number and length of branches, as well as
the number and area of lamellipodia were quantified and then
averaged over the total period.
OECs in control medium, displayed distinct alterations in
morphology occurring over 30 min or more (Fig. 7A). Curcumin
treatment (0.5 mM) resulted in morphology changes in OECs, in
particular the presence of large, active lamellipodia (Fig. 7B). After
6 h incubation, OECs in control medium continued to exhibit a
bipolar morphology, often displaying a single process emanating
from the cell body (arrow in Fig. 7C) and a large lamellipodia
directly protruding from the other polar end of the cell body
(asterisk, Fig. 7C). Curcumin-treated OECs also had a largely
bipolar appearance but, in contrast to control OECs, they rapidly
produced and retracted additional branches or lamellipodia over
time (Fig. 7D). Incubation with curcumin significantly increased
all parameters assessed, indicating that curcumin modulates the
morphology of OECs by increasing the number and length of
branches and the number and area of lamellipodia for up to at
least 24 h (Fig. 7E–H). G5 supplement treatment did not show
any significant difference compared with the control, in any of the
factors examined. We have previously reported that growth factors
such as GDNF stimulate proliferation, mediate migration and
have an effect on lamellipodial activity of OECs [41]. As well,
previous studies have reported that OECs undergo morphological
changes and reorganization of cytoskeleton before functioning as
phagocytes and engulfing apoptotic neuron debris [6] as observed
in the phagocytosis assays.
In OECs, it has been shown that changes in peripheral
lamellipodia are a result of activation of the enzyme MEK1 (ERK
kinases pathway) after stimulation with GDNF [33]. The
stimulation of lamellipodial activity led to increased cell-cell
contact and resulted in contact-mediated migration [33,41].
Additionally, after olfactory bulbectomy, in the absence of axons,
extensive OEC cell-cell contact resulted in subsequent superior
OEC proliferation and axon growth [65]. Our current results
show that curcumin had a distinct effect on lamellipodial activity
of OECs and that the changes in proliferation and migration could
be as a result of the increased cell-cell contact that is induced by
curcumin. We addressed this by evaluation of changes in the
number and area of lamellipodia in OECs treated with p38 and
ERK kinase inhibitors and found that fewer lamellipodia were
present in cells treated by the ERK inhibitor (Fig. 7I). Thus, the
increase of proliferation by curcumin is likely to act via a
combination of direct stimulation of proliferation via the p38 MAP
and ERK pathways and indirectly via modification of cell-cell
contact via the ERK pathway.
OECs combined with GDNF have been trialled for neural
transplant therapies and resulted in improved regeneration of the
optic nerve [66] and spinal cord [67] due to the enhancement on
the activity of lamellipodia, resulting in increased migration rate of
OECs [33,41]. In this study, we also showed that low-dose
curcumin promoted OEC migration, and increased lamellipodial
activity. Therefore, GDNF and curcumin appear to have similar
effects on OECs. However, one important difference is that unlike
GDNF, curcumin also increased the proliferation rate of OECs.
Moreover, the adoption of the bipolar morphology at low
concentrations of curcumin is likely to be more suitable for
promoting migration of OECs in neural transplant therapies, as it
has been shown that OECs with the bipolar morphology are more
motile whereas OECs with the flattened morphology in which
large lamellipodial surround the cells have lower rates of migration
[17,32,33]. Curcumin’s effects on extension of OEC’s lamellipodia
and cell-cell contact may be ideal for stimulating proliferation of
glia whilst maintaining the morphology most amenable for
migration.
After widespread degeneration of sensory neurons within the
olfactory system, the axons that initially regenerate often project to
incorrect target sites [68] or are limited to the periphery of the
injury site when target tissue is removed [65]. However, when
OECs are transplanted into the injury site the glia create a
uniform environment which leads to superior axon regeneration
[65]. Since we have now shown that curcumin increases the
proliferation and migration of OECs, it may increase the density of
transplanted OECs in neural transplant therapies, promote cell-
cell contact via stimulating peripheral lamellipodia and subse-
quently lead to increase production of neurotrophic factors [69]
that will together promote extension of axons across the injury site
(Fig. 8). Moreover, the remarkable enhancement of the OEC
phagocytic activity by curcumin could promote a clean beneficial
environment essential for axon regeneration and survival [19].
It is also important to note that is necessary to improve
curcumin’s in vivo bio-availability to enhance its utility as
therapeutic agent [70]. Animal studies have reported that
curcumin undergoes fast metabolism by conjugation and reduc-
tion [26] and its disposition after oral dosing is characterized by
poor systemic bioavailability [71,72]. Several studies have been
undertaken to enhance the bio-availability of curcumin, resulting
in new strategies that enhance bioactivity and significantly increase
the bio-availability of curcumin in vivo [73–75] such as structural-
related modifications and synthesis of new curcumin derivatives.
In conclusion, here we present the first evidence that low dose
curcumin significantly stimulated dynamic changes in morpholo-
gy, resulting in increased migration and proliferation, as well as a
dramatic increase in the phagocytic activity. These results suggest
that curcumin may have an important potential in stimulating
OECs therapeutic properties that could be of relevance for neural
transplant therapies.
Supporting Information
Table S1 Primary and secondary antibodies.
(DOCX)
Movie S1 Time-lapse movie of OECs with axonal debris
in control medium. Select frames are shown in Fig. 5G. Time
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Movie S2 Time-lapse movie of OECs with axonal debris
in medium with 0.5 mM curcumin. Select frames are shown
in Fig. 5H. Time is h:min.
(MPG)
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